Skip to main content
Signal8

ENCISION INC (ECIA)

Encision Inc. (ECIA), established in 1991 and headquartered in Boulder, Colorado, operates as a medical device firm specializing in the development, manufacturing, and commercialization of proprietary surgical instruments for the U.S. market. The company's core offering revolves around its patented Active Electrode Monitoring (AEM) technology, featured in both surgical instruments and dedicated monitors. This innovative system significantly enhances patient safety and optimizes outcomes during laparoscopic surgical procedures. Encision's AEM instrument portfolio encompasses a diverse array of endo-mechanical tools, such as scissors, graspers, and dissectors, alongside specialized fixed-tip and suction-irrigation electrodes. Beyond these, the company supplies specialized handles designed for complex laparoscopic operations, characterized by their robust shafts and ergonomic designs. They also provide the AEM EndoShield 2 burn protection systems. Complementing these instruments, Encision markets its AEM monitor product line, essential for use in conjunction with its AEM instruments. Distribution of Encision's products occurs through a hybrid sales model, leveraging both direct company representatives and an established network of independent sales agents.

Sector: Surgical & Medical Instruments & Apparatus

Industry: Medical - Instruments & Supplies

Encision Inc. logo

Encision Inc.

OTC:ECIAHealthcare
Mkt Cap$194K
Float6.26M
O/S16.88M
Inst Own-
SI0.1%
Dilution
Historical Data
DateOpenHighLowCloseVolume
Key Metrics
Market Cap$194,116
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership0.00%

based on 16.88M shares outstanding

SectorHealthcare
IndustryMedical - Instruments & Supplies
ExchangeOTC
CountryUSUS
IPO DateJan 2, 2004
Shares Outstanding16.88M
Float6.26M
Company Overview

Encision Inc. (ECIA), established in 1991 and headquartered in Boulder, Colorado, operates as a medical device firm specializing in the development, manufacturing, and commercialization of proprietary surgical instruments for the U.S. market.

The company's core offering revolves around its patented Active Electrode Monitoring (AEM) technology, featured in both surgical instruments and dedicated monitors. This innovative system significantly enhances patient safety and optimizes outcomes during laparoscopic surgical procedures. Encision's AEM instrument portfolio encompasses a diverse array of endo-mechanical tools, such as scissors, graspers, and dissectors, alongside specialized fixed-tip and suction-irrigation electrodes. Beyond these, the company supplies specialized handles designed for complex laparoscopic operations, characterized by their robust shafts and ergonomic designs. They also provide the AEM EndoShield 2 burn protection systems. Complementing these instruments, Encision markets its AEM monitor product line, essential for use in conjunction with its AEM instruments. Distribution of Encision's products occurs through a hybrid sales model, leveraging both direct company representatives and an established network of independent sales agents.

Leadership

David W. Newton

Co-Founder

Gregory J. Trudel

Director, President & CEO

Patrick W. Pace, M.D.

Director

Robert H. Fries

Interim President, CEO & Director

Employees

22

Country

US

Sector

Healthcare

Website

encision.com

Analyst Coverage
No analyst coverage for this companyNo ratings, price targets, or covering firms on file.
Insider Trades
InsiderTypeShares
JACKMAN BRIAN J profile photoJACKMAN BRIAN JGrant/Award10.0K
Trudel Gregory J. profile photoTrudel Gregory J.Grant/Award10.0K
Shepard Brandon Jason profile photoShepard Brandon JasonPurchase1.00M
FRIES ROBERT H profile photoFRIES ROBERT HPurchase750.0K
Trudel Gregory J. profile photoTrudel Gregory J.Purchase1.00M
KORNELSEN VERN D profile photoKORNELSEN VERN DGrant/Award10.0K
Shareholders
0.0%
Institutional
(0)
53.8%
Insiderⓘ
(6)
0.0%
5%+ Owners
(0)
46.2%
Unattributed (incl. retail)ⓘ
Insider53.8%
Unattributed (incl. retail)46.2%
Sources: Form 4O/S: 16.9M · as of 10 Nov 2025 · SEC cover page
Insiders & Institutional Holders

Insiders

52-Week Range
Volume
Average Daily Volume25.23K

30d Avg

25.23K

60d Avg

13.25K

90d Avg

10.07K

Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...